Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Transactions

Kevin Feeley, CFO of GeneDx Holdings Corp., reports the acquisition and disposal of Class A Common Stock related to restricted stock units.

Summary

• On September 1, 2024, Kevin Feeley, CFO of GeneDx Holdings Corp., acquired 717 shares of Class A Common Stock upon the vesting of restricted stock units (RSUs) at a price of $0.
• On September 3, 2024, Feeley sold 262 shares of Class A Common Stock at a weighted average price of $31.7096 per share, with prices ranging from $31.6053 to $31.71.
• The sale was to cover tax withholding obligations related to the vesting of the RSUs and was not a discretionary transaction.
• Following these transactions, Feeley beneficially owns 38,343 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the trading activities of key personnel.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve a small number of shares relative to the company's total outstanding shares.
• The sale of shares to cover tax obligations is a standard practice and does not indicate any change in the executive's confidence in the company.

Key Dates